Adam R.D. PaineAssociateK&L Gates LLPWebsitewww.klgates.comConnectEmail617-951-9189 Professional Biography Adam Paine is an associate in the firm’s Boston office focusing his practice on general civil and commercial litigation matters. More Legal and Business Bylines From Adam R.D. Paine Lawyer and Witness? Not so fast. Chancery Warns Trial Counsel That His Plan To Testify Flouts Ethical Rules - (Posted On Thursday, October 28, 2021) Litigation Minute: Litigation Holds in the Investment Management Industry - (Posted On Tuesday, August 24, 2021) Strength In Numbers: The Seventh Circuit Joins The Third And Eleventh Circuits In Limiting The Definition Of An Automatic Telephone Dialing System Under The TCPA - (Posted On Wednesday, February 26, 2020) Current Legal Analysis Jury Sides with Penn State in Vintage Trademark Case by: Sara M. Bauer The 2025 Final Hospital Outpatient Prospective Payment System and Physician Fee Schedule Rules: What Pharma Stakeholders Need to Know by: Stephanie Trunk , Shoshana Golden Balancing the Scales: How to Use “Legitimate Interest” to Process Personal Data “Fairly” by: Charles-Albert Helleputte , Claire Murphy Senate Judiciary Subcommittee Holds Back Two Key Patent Reform Bills by: Christopher M. Bruno UPC Court of Appeal Rules on Suspending First Instance Enforcement, Managing Director Liability by: Lisa Nassi FINRA Facts and Trends: November 2024 by: Joshua Klein , Russell W. Gallaro Upcoming Events Dec 10 2024 Legal AI Week 2024 Nov 21 2024 Third-Party Litigation Funding through a Transatlantic Lens Nov 21 2024 CC&Rs and Easements for Mixed-Use Projects: Best Practices for Developers Nov 21 2024 AI Patent Eligibility: Processing the USPTO's New Guidance Nov 21 2024 Update of 2024 California Employment Law Cases Nov 25 2024 2024 Election: Impact on the Health Care Legal and Policy Landscape Webinar Dec 4 2024 TSCA 30/30 - December 4, 2024 Dec 4 2024 GLP-1 Drugs: What's Next after FDA's Resolution of Drug Shortages Print
